Z-1604-2024 Class II Ongoing
FDA device recall Z-1604-2024 was initiated by Parker Laboratories, Inc. on Mar 22, 2024 and is designated Class II. Reason for recall: Product demonstrates low viscosity. The recall status is ongoing. Affected quantity: 217 cases (1,085 Inner Boxes; 10,850 Eaches).
Recall details
- Product Type
- Devices
- Report Date
- May 1, 2024
- Initiation Date
- Mar 22, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 217 cases (1,085 Inner Boxes; 10,850 Eaches)
Product description
Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.
Reason for recall
Product demonstrates low viscosity.
Distribution pattern
Worldwide distribution - US Nationwide in the states of CA, CO, FL, GA, IL, MD, MI, MN, NC, NE, NY, OH, PA, SC, & TX. The countries of AU, CA, OM, & SA.
Code information
Product No. 66-04; UDI: 20855683006399 (Master), 10855683006392 (Inner Box), 00855683006395 (Each); Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26).
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1604-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026